Alvarez & Marsal Taxand Managing Director, Al Liguori, was quoted in the Bloomberg.com article “AbbVie Moves Allergan Profits to U.S. in Partial GOP Tax Law Win.”
"The 2017 tax overhaul cut the rate from 35% to 21% and killed off nearly all remaining reasons for companies to invert. But Allergan will likely have to pay a new tax in the law on what is known as global intangible low-taxed income, or GILTI, said Albert W. Liguori, managing director at consulting firm Alvarez & Marsal Taxand."
Click here to read the full article.
This article was originally published on Bloomberg.com on June 26th. ©2019 Bloomberg L.P.
A&M Tax Policy Insights – December 2025
January 23, 2026
A&M's December 2025 Tax Policy Insights: Expert analysis and global updates on treaties, tariffs, and regulatory shifts affecting cross‑border compliance.
How a Lake of Data Can Power Your Strategic Tax Centre
January 22, 2026
Turn fragmented tax data into a strategic advantage. Discover how building a robust Lake of Data can unlock automation, reduce risk, and empower your tax function to move beyond compliance.
India Updates Insurance Framework, Allowing Full Foreign Ownership and Governance Changes
January 21, 2026
India has announced landmark reforms to its insurance framework, permitting 100% foreign ownership and introducing more flexible governance norms.
The changes aim to attract global capital, enhance regulatory oversight, and strengthen policyholder protection.
Senior Accounting Officer (SAO) Legislation: An Overview
January 21, 2026
This article provides an overview of the Senior Accounting Officer (SAO) legislation, designed to inform those who may be impacted.
